Skip to main content
. 2018 Nov 21;33(49):e323. doi: 10.3346/jkms.2018.33.e323

Table 3. Factors related with INR control (n = 852).

Characteristics WC PC P value
Sex, male 131 (58.0) 381 (60.9) 0.4457a
Age, yr 71.77 (7.78) 66.20 (10.42) < 0.0001b
BMI 24.69 (3.32) 24.87 (3.29) 0.5242b
NVAF duration, mon 21.03 (40.42) 17.44 (31.59) 0.8384c
Type of NVAF 0.8887a
First diagnosed 27 (12.0) 65 (10.4)
Paroxysmal 68 (30.1) 195 (31.2)
Persistent 85 (37.6) 250 (39.9)
Long-standing persistent 13 (5.8) 30 (4.8)
Permanent 24 (10.6) 56 (9.0)
Unknown 9 (4.0) 30 (4.8)
Mental co-morbid conditions, yes 14 (6.2) 25 (4.0) 0.1747a
Employment, yes 56 (24.9) 247 (39.7) < 0.0001a
Alcohol use 0.0775a
Non-drinker 111 (49.1) 256 (40.9)
Past drinker 55 (24.3) 162 (25.9)
Current drinker 60 (26.6) 208 (33.2)
Smoking 0.0577a
Non-smoker 140 (62.0) 356 (56.9)
Past smoker 74 (32.7) 204 (32.6)
Current smoker 12 (5.3) 66 (10.5)
Education 0.9384a
No education 18 (8.0) 48 (7.8)
≤ Elementary school 52 (23.1) 157 (25.4)
≤ Middle school 34 (15.1) 94 (15.2)
≤ High school 62 (27.6) 173 (28.0)
≤ University 47 (20.9) 123 (19.9)
≥ Post-graduation school 12 (5.3) 24 (3.9)
CHADS2 score 1.92 (0.89) 1.83 (0.97) 0.0637c
CHA2DS2-VASc score 3.21 (1.21) 2.85 (1.43) 0.0002b
HAS-BLED score 1.41 (0.63) 1.52 (0.66) 0.0292c
VKA dosage, mg/day 19.51 (7.61) 19.36 (9.84) 0.8190b
VKA treatment 0.0003a
Continue 189 (83.6) 446 (71.3)
Discontinued & switching 22 (9.7) 446 (71.3)
Discontinued & no switching 15 (6.6) 44 (7.0)

Data are presented as mean (standard deviation) or number (%).

INR = international normalized ratio, WC = well-controlled, PC = poor-controlled, BMI = body mass index, NVAF = non-valvular atrial fibrillation, VKA = vitamin K antagonist.

aP value calculated by χ2 test; bP value calculated by Student's t-test; cP value calculated by Mann-Whitney's U test.